Sign in

CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880277072
Phone
(713) 400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. POS AM Other Post-effective Amendment for Registration Statement
  5. POS AM Other Post-effective Amendment for Registration Statement
  6. 8-K Event Unregistered share sale
  7. SC 13D/A Stake Beneficial Ownership Report
  8. 4 Insider Changes in Ownership
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 8-K Event Material agreement
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 8-K Event Material agreement · Unregistered share sale
  13. 4 Insider Changes in Ownership
  14. 10-Q Report Quarterly Report
  15. 10-K Report Annual Report
  16. NTN 10K Other NTN 10K
  17. 8-K Event Executive or director change
  18. SC 13D Stake Beneficial Ownership Report
  19. 3 Insider Initial Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 27 of 46 · 904 filings